Actively Recruiting
Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis
Led by Shaheed Zulfiqar Ali Bhutto Medical University · Updated on 2024-08-05
60
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Root canal therapy (RCT) is a classical and effective treatment that is currently utilised in dental practice, offering high success rates for pulp and periapical diseases; however, teeth after RCT are susceptible to altered pulp defence and sensory function, even fractures, as a consequence of pulp loss. Furthermore, several studies have highlighted that the actual failure rate of standard root canal treatments performed in general practice is significantly higher than expected . Moreover, these treatments are lengthy and costly and are often subject to retreatment .Inherent in this procedure(rct) is loss of dental hard tissue and subsequent weakening of the treated tooth,making them more prone to fracture. Therefore, less invasive alternative strategies could be used to treat pulpitis, even when irreversible. Murray et al. proposed the term "Regenerative endodontic treatment (RET)" in 2007, based on a tissue engineering concept (stem cells, biomimetic scaffolds, and bioactive growth factors). The 2016 American Association of Endodontists (AAE) guidelines formally defined RET as a collection of "biologically based procedures designed to replace damaged tooth structures, including dentine and root structures, as well as cells of the pulp-dentine complex"
CONDITIONS
Official Title
Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 to 35 years
- Permanent teeth with mature roots diagnosed with irreversible pulpitis, with apex absorption damage and apical hole diameter greater than 1 mm
- A tooth that can be restored
- No need to leave space for final post/core restoration
- Anterior teeth and premolars with a single canal
- Cooperative and compliant patients
- No allergy to drugs or antibiotics needed for treatment
- No periodontal disease or root cracking
You will not qualify if you...
- Serious organ diseases such as cardiopulmonary, kidney, or other major illnesses
- Pregnant, breastfeeding, or expecting pregnancy within one year
- Presence of apical cysts
- Poor cooperation or quitting the study early
- Periodontitis
- Dental dysplasia or other genetic oral disorders
- Dental phobia
- Mental disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dr Shahbaz Saqib
Islamabad, ICT, Pakistan, 44080
Actively Recruiting
Research Team
D
Dr Shahbaz Saqib, BDS
CONTACT
N
Nasar Um Min Allah, BDS,MSD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here